Similar articles for PMID: 18292102

Year	Number of Results
1998	1
2000	2
2002	4
2003	3
2005	1
2006	7
2007	4
2008	3
2009	5
2010	4
2011	6
2012	4
2013	7
2014	9
2015	8
2016	5
2017	12
2018	9
2019	9
2020	2
2021	4
2022	4
2023	1
2024	0

1

Can clinical factors at presentation be used to predict outcome of treatment with methotrexate in patients with early inflammatory polyarthritis?

Hider SL, Silman AJ, Thomson W, Lunt M, Bunn D, Symmons DP. Hider SL, et al. Ann Rheum Dis. 2009 Jan;68(1):57-62. doi: 10.1136/ard.2008.088237. Epub 2008 Feb 21. Ann Rheum Dis. 2009. PMID: 18292102 Free PMC article.

2

Risk factors for oral methotrexate failure in patients with inflammatory polyarthritis: results from a UK prospective cohort study.

Bluett J, Sergeant JC, MacGregor AJ, Chipping JR, Marshall T, Symmons DPM, Verstappen SMM. Bluett J, et al. Arthritis Res Ther. 2018 Mar 20;20(1):50. doi: 10.1186/s13075-018-1544-9. Arthritis Res Ther. 2018. PMID: 29554956 Free PMC article.

3

Prediction of primary non-response to methotrexate therapy using demographic, clinical and psychosocial variables: results from the UK Rheumatoid Arthritis Medication Study (RAMS).

Sergeant JC, Hyrich KL, Anderson J, Kopec-Harding K, Hope HF, Symmons DPM; RAMS Co-Investigators; Barton A, Verstappen SMM. Sergeant JC, et al. Arthritis Res Ther. 2018 Jul 13;20(1):147. doi: 10.1186/s13075-018-1645-5. Arthritis Res Ther. 2018. PMID: 30005689 Free PMC article.

4

Biologic or tofacitinib monotherapy for rheumatoid arthritis in people with traditional disease-modifying anti-rheumatic drug (DMARD) failure: a Cochrane Systematic Review and network meta-analysis (NMA).

Singh JA, Hossain A, Tanjong Ghogomu E, Mudano AS, Tugwell P, Wells GA. Singh JA, et al. Cochrane Database Syst Rev. 2016 Nov 17;11(11):CD012437. doi: 10.1002/14651858.CD012437. Cochrane Database Syst Rev. 2016. PMID: 27855242 Free PMC article. Review.

5

Comparing the long-term clinical outcome of treatment with methotrexate or sulfasalazine prescribed as the first disease-modifying antirheumatic drug in patients with inflammatory polyarthritis.

Hider SL, Silman A, Bunn D, Manning S, Symmons D, Lunt M. Hider SL, et al. Ann Rheum Dis. 2006 Nov;65(11):1449-55. doi: 10.1136/ard.2005.049775. Epub 2006 Mar 15. Ann Rheum Dis. 2006. PMID: 16540547 Free PMC article. Clinical Trial.

6

Baseline factors predicting change from the initial DMARD treatment during the first 2 years of rheumatoid arthritis: experience in the ERAN inception cohort.

McWilliams DF, Kiely PD, Young A, Walsh DA. McWilliams DF, et al. BMC Musculoskelet Disord. 2013 May 1;14:153. doi: 10.1186/1471-2474-14-153. BMC Musculoskelet Disord. 2013. PMID: 23634781 Free PMC article.

7

Development and validation of a prognostic multivariable model to predict insufficient clinical response to methotrexate in rheumatoid arthritis.

de Rotte MCFJ, Pluijm SMF, de Jong PHP, Bulatović Ćalasan M, Wulffraat NM, Weel AEAM, Lindemans J, Hazes JMW, de Jonge R. de Rotte MCFJ, et al. PLoS One. 2018 Dec 10;13(12):e0208534. doi: 10.1371/journal.pone.0208534. eCollection 2018. PLoS One. 2018. PMID: 30532219 Free PMC article.

8

Contemporary use of disease-modifying drugs in the management of patients with early rheumatoid arthritis in Norway.

Nikolaisen C, Kvien TK, Mikkelsen K, Kaufmann C, Rødevand E, Nossent JC. Nikolaisen C, et al. Scand J Rheumatol. 2009;38(4):240-5. doi: 10.1080/03009740802609566. Scand J Rheumatol. 2009. PMID: 19229766

9

Longterm combination therapy of refractory and destructive rheumatoid arthritis with methotrexate (MTX) and intramuscular gold or other disease modifying antirheumatic drugs compared to MTX monotherapy.

Rau R, Schleusser B, Herborn G, Karger T. Rau R, et al. J Rheumatol. 1998 Aug;25(8):1485-92. J Rheumatol. 1998. PMID: 9712088 Clinical Trial.

10

Inadequate response to treat-to-target methotrexate therapy in patients with new-onset rheumatoid arthritis: development and validation of clinical predictors.

Teitsma XM, Jacobs JWG, Welsing PMJ, de Jong PHP, Hazes JMW, Weel AEAM, Pethö-Schramm A, Borm MEA, van Laar JM, Lafeber FPJG, Bijlsma JWJ. Teitsma XM, et al. Ann Rheum Dis. 2018 Sep;77(9):1261-1267. doi: 10.1136/annrheumdis-2018-213035. Epub 2018 May 14. Ann Rheum Dis. 2018. PMID: 29760159 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

100 results

Results by year